EFSA management board responds to new NGO report, defends EFSA’s new transparency policy
EFSA considers 3 PET recycling processes as safe
EFSA publishes 3 scientific opinions on processes used to recycle post-consumer PET, considers “Starlinger Decon” based processes, “CPR Superclean PET” and “4PET” processes safe
EFSA: Sharing models and tools
European Food Safety Authority (EFSA) provides public access to its scientific models and tools through the Knowledge Junction community and Statistical Models platform; aims at ‘improving transparency, reproducibility and evidence reuse’
EFSA publishes EDC report
EFSA suggests risk assessment for endocrine disrupting chemicals (EDCs) and raises criticisms from NGOs and industry
EFSA publishes scientific opinion on PFAS in food
European Food Safety Authority’s (EFSA) latest draft opinion proposes group tolerable weekly intake (TWI) limit of 8 ng/kg body weight for 4 per- and polyfluoroalkyl substances (PFAS); opens public comment period until April 20, 2020, plans technical workshop in Brussels on March 12, 2020
EFSA’s conflicts of interest analyzed
NGO Corporate Europe Observatory publishes report on EFSA’s independence policy, shows 46% of the authority’s experts have conflicts of interest
EFSA: Consultations on weight of evidence and biological relevance
EFSA announces public consultation on two draft guidance documents concerning use of weight of evidence approach in scientific assessments and identification of biological relevance of observed effects
EFSA publishes hazard assessment protocol for reevaluation of FCM plasticizers
European Food Safety Authority’s (EFSA) protocol outlines strategy for collecting data and appraising evidence for hazard assessment of phthalates and other plasticizers in food contact materials (FCMs); latest step in agency’s reevaluation of risks to public health
EFSA: 3 PET recycling processes
EFSA considers PET recycling processes “LPR”, “APPE Supercycle B” and “FPR” safe for food contact
EFSA’s work on endocrine disrupters is ongoing
EFSA gives update on their work on endocrine active substances and non-monotonic dose response; following up their Scientific Opinion of 2013